NOT-EY-23-007: Notice of NEI Participation in RFA-OD-23-051, "Emergency Award: RADx-UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)"

Notice of NEI Participation in RFA-OD-23-051, "Emergency Award: RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)"

Notice Number:

NOT-EY-23-007

Key Dates

Release Date:

May 16, 2023

Related Announcements

June 20, 2023 - Notice of Change to Funding Opportunity: RADx-UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional). See Notice NOT-OD-23-138

June 20, 2023 - Notice of Change to Funding Opportunity: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed). See Notice NOT-OD-23-141

May 2, 2023 - Emergency Award: RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional). See Notice RFA-OD-23-051.

Issued by

National Eye Institute (NEI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Eye Institute (NEI) will participate in Notice of Funding Opportunity (NOFO) RFA-OD-23-051 - Emergency Award: RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional), with July 10, 2023, as application due date.

The following sections of the RFA-OD-23-051 have been modified (changes shown in bold italics) to reflect the participation of NEI in this funding opportunity.

Part 1. Overview Information

Components of Participating Organizations

Office of The Director, National Institutes of Health (OD)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of General Medical Sciences (NIGMS)

National Institute of Mental Health (NIMH)

National Institute on Minority Health and Health Disparities (NIMHD)

National Library of Medicine (NLM)

National Center for Advancing Translational Sciences (NCATS)

National Cancer Institute (NCI)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Sexual and Gender Minority Research Office (SGMRO)

Office of Behavioral and Social Sciences Research (OBSSR)

Assistance Listing Number(s)

93.855, 93.279, 93.865, 93.307, 93.866, 93.399, 93.273, 93.859, 93.879, 93.113, 93.837, 93.839, 93.840, 93.233, 93.846, 93.350, 93.242, 93.847, 93.867

Section VII. Agency Contacts

Scientific/Research Contact(s)

Cheri Wiggs, PhD
National Eye Institute (NEI)
Telephone: (301) 402-0276
Email: wiggsc@mail.nih.gov

Financial/Grants Management Contact(s)

Karen Robinson Smith
National Eye Institute (NEI)
Telephone: 301-435-8178
Email: Karen.Robinson.Smith@nei.nih.gov

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Cheri Wiggs, PhD
National Eye Institute (NEI)
Telephone: (301) 402-0276
Email: wiggsc@mail.nih.gov